報價延遲最少15分鐘:2025/07/07 00:36 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
22.84 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.23/0.05
|
|
企業價值
1.10B
|
| 資產負債 |
|
每股賬面淨值
7.41
|
| 現金流量 |
|
現金流量率
0.01
|
| 損益表 |
|
收益
82.25M
|
|
每股收益
3.41
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 00:36 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States. |